Ivermectin (Compound)

Synonyms:IVERMECTIN, Ivermectin B1a, 70288-86-7, Dihydroavermectin B1a, 22,23-Dihydroavermectin B1a, avermectin H2B1a, UNII-91Y2202OUW, 71827-03-7, 70161-11-4, Ivermectin Component B1a, CHEBI:63941, 91Y2202OUW, (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-Butan-2-Yl]-20,20b-Dihydroxy-5',6,8,19-Tetramethyl-17-Oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-Tetradecahydro-2h,7h-Spiro[11,15-Methanofuro[4,3,2-Pq][2,6]benzodioxacyclooctadecine-13,2'-Pyran]-7-Yl 2,6-Dideoxy-4-O-(2,6-Dideoxy-3-O-Methyl-Alpha-L-Arabino-Hexopyranosyl)-3-O-Methyl-Alpha-L-Arabino-Hexopyranoside, 5-O-demethyl-22,23-dihydroavermectin A1a, (1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one, C48H74O14 (B1a form), Ivermectin B1a-d2, MK-933, C48H74O14, 22,23-Dihydroavermectin B(1)a, NCGC00163233-01, Ivermectin (IVM), IVM, EINECS 276-046-2, dihydro avermectin Bla, BRN 4643153, 22,23-Dihydro-5-O-demethylavermectin A1a, H2B1a, Prestwick3_000156, DSSTox_CID_3181, Ivermectin (MK-0933), DSSTox_RID_76909, DSSTox_GSID_23181, BSPBio_000292, SCHEMBL312795, BPBio1_000322, CHEMBL263291, DTXSID8023181, CHEBI:94551, HMS2089M09, HMS2095O14, HMS3712O14, WCA82703, Tox21_112034, BDBM50409816, MFCD00869511, s1351, AKOS027470116, ZINC238808778, ZINC252286706, AC-6014, CCG-220156, NCGC00186639-01, NCGC00186639-03, AS-14167, BI166167, CAS-71827-03-7, HY-126937, AB00513813, CS-0108408, J10179, 22,23-DIHYDROAVERMECTIN B1A; IVERMECTIN, AB00513813-02, AB00513813-03, AB00513813_04, Avermectin A1a, 22,23-dihydro-5-O-demethyl-, 288I867, Ivermectin, Antibiotic for Culture Media Use Only, Q-201262, BRD-K24652731-001-02-7, BRD-K85554912-001-08-9, Q27132923, Ivermectin, British Pharmacopoeia (BP) Reference Standard, Ivermectin, European Pharmacopoeia (EP) Reference Standard, UNII-8883YP2R6D component AZSNMRSAGSSBNP-XPNPUAGNSA-N, Ivermectin, United States Pharmacopeia (USP) Reference Standard, Ivermectin, Pharmaceutical Secondary Standard; Certified Reference Material, (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17, 22,23-Dihydroavermectin B1|||Heartgard 30|||Ivomec|||Ivosint|||Mectizan|||Stromectol|||Uvemec|||Vermic|||Zimecterin, clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
Pubchem:PUBCHEM:3085416
Id:cc1610e0-de45-5883-9d9b-a74494ec88dd
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ivermectin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ivermectin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ivermectin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.